Introduction to RabMAb® primary antibody technology webinar

Overview

RabMAb^® technology is Abcam's unique Rabbit Monoclonal Antibody technology. This technology combines the superior antigen recognition of a rabbit antibody with the specificity and consistency of a monoclonal.

Join Weimin Zhu, the RabMAb technology founder, for this introduction.

Learn why RabMAb^® technology

Provides higher affinity and specificity compared to traditional antibodies

Often gives lower background signal compared to traditional antibodies

Provides diverse epitope recognition

Is ideal for studying mouse models

Is ideal for demanding applications like IHC on FFPE tissue

Watch now

Professional Email Address*

Country / Region*

^{^{Abcam will process your personal data in strict accordance with its privacy policy which can be found here. This will include sending you updates about Abcam, our products, and resources we think would be of interest to you. You can unsubscribe and manage your marketing preferences by clicking the link at the bottom of every email we send. By filling out this form you consent to Abcam sharing your details with your local, authorized distributor for the purpose of answering your query.}}

Meet our presenter

Meet our presenter

Mr. Weimin Zhu

Mr. Weimin Zhu received his M.S. in Cell Biology at Xiamen University, China. He was a Senior Research Fellow at the Institute of Pathology of Zhejiang Medical University where he began his monoclonal antibody study. He then moved to University of California San Francisco as a senior associate specialist, where he pioneered rabbit monoclonal antibody technology (created new rabbit fusion partner 240E-W) and established the high-throughput system for rabbit hybridoma generation.

Overview

Learn why RabMAb® technology

Watch now

Meet our presenter

Meet our presenter

Learn why RabMAb^® technology